PMV Pharmaceuticals, Inc. (PMVP) - Quarterly Income Statement

Home
PMVP
Financials

1.52 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	1.618	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.372	0.362	0.359	0.358	0.369	0.082	0.16	0.144	0.179	0.167	0.407	0.41	0.071	0.079	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-0.372	-0.362	1.259	-0.358	-0.369	-0.082	-0.16	-0.144	-0.179	-0.167	-0.407	-0.41	-0.071	-0.079	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.778	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	14.256	12.824	13.023	13.586	13.843	15.073	15.025	13.666	11.462	11.836	12.167	9.162	7.664	7.5	6.181	5.992	5.804	5.955	5.699	4.895	5.083	5.083
General & Administrative Expenses Numbers are in millions	5.542	5.035	5.52	6.042	6.279	6.407	6.137	5.709	6.423	6.783	6.305	5.935	5.386	4.174	4.32	2.709	2.281	1.699	1.656	1.545	1.338	1.338
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	5.542	5.035	5.52	6.042	6.279	6.407	6.137	5.709	6.423	6.783	6.305	5.935	5.386	4.174	4.32	2.709	2.281	1.699	1.656	1.545	1.338	1.338
Other Expenses Numbers are in millions	-0.017	-0.001	-0.021	0.004	-0.006	0.027	0.02	0.013	-0.031	-0.041	0.007	0.003	0.063	-0.052	0	-0.1	-0.039	-0.005	0	0	0	0
Operating Expenses Numbers are in millions	19.798	17.859	18.543	19.628	20.122	21.48	21.162	19.375	17.885	18.619	18.472	15.097	13.05	11.674	10.501	8.701	8.085	7.654	7.355	6.44	6.413	6.413
Operating Income Numbers are in millions	-20.17	-18.221	-18.902	-19.628	-20.122	-21.48	-21.162	-19.375	-17.885	-18.619	-18.472	-15.097	-13.05	-11.674	-10.501	-8.701	-8.085	-7.654	-7.355	-6.44	-6.421	-6.421
Operating Income Ratio Numbers are in millions	0	0	-11.682	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	2.784	2.951	3.145	2.988	-0.006	2.352	1.817	1.137	0.573	0.188	0.007	0.003	0.063	-0.052	0.048	-0.1	-0.039	-0.005	0.308	0.272	0.365	0.365
Income Before Tax Numbers are in millions	-17.386	-15.27	-15.757	-16.64	-17.432	-19.128	-19.345	-18.238	-17.312	-18.431	-18.359	-14.992	-12.874	-11.598	-10.453	-8.761	-7.967	-7.253	-7.047	-6.168	-6.056	-6.056
Income Before Tax Ratio Numbers are in millions	0	0	-9.739	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	-16.173	0.319	-0.001	-0.358	0.004	-2.352	-0.018	-0.009	-0.002	0.002	0.023	0.019	-0.113	0.004	0.001	0.003	-0.157	0.002	0	0.007	0.001	0.001
Net Income Numbers are in millions	-1.213	-15.27	-15.756	-16.64	-17.436	-16.776	-19.327	-18.229	-17.31	-18.433	-18.359	-15.011	-12.874	-11.602	-10.454	-8.764	-7.967	-7.255	-7.047	-6.175	-6.057	-6.057
Net Income Ratio Numbers are in millions	0	0	-9.738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.024	-0.3	-0.31	-0.34	-0.38	-0.37	-0.42	-0.4	-0.38	-0.41	-0.41	-0.33	-0.29	-0.26	-1.74	-1.46	-0.19	-0.23	-0.23	-0.2	-2	-2
EPS Diluted Numbers are in millions	-0.024	-0.3	-0.31	-0.34	-0.38	-0.37	-0.42	-0.4	-0.38	-0.41	-0.41	-0.33	-0.29	-0.26	-1.74	-1.46	-0.19	-0.23	-0.23	-0.2	-2	-2
EBITDA Numbers are in millions	-19.798	-17.859	-18.543	-19.628	-19.753	-21.309	-21.087	-19.301	-17.803	-18.535	-18.395	-15.017	-12.979	-11.595	-10.44	-8.701	-7.997	-7.56	-7.26	-6.333	-6.328	-6.328
EBITDA Ratio Numbers are in millions	0	0	-11.46	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP Add to watchlist

NASDAQ:PMVP